Skip to content
ReviewRamble

The weekly brief

AI, reviewed, in your inbox.

  • New reviews of tools, models, MCP servers and repos, with the verdict up front
  • Re-checked prices and ratings when something changes
  • New analysis pieces as they are published

Models, agents, MCP servers and the tools actually worth your time.

One email a week. Unsubscribe with the link in any brief. How we use your email

AI news & research

Research ·

Researchers set out guidelines for judging AI protein-ligand binding predictors

A Perspective in Nature Machine Intelligence by Ballester and Tran-Nguyen argues that deep learning scoring functions for drug design have become hard to compare across studies. They call for open training data, code and procedures, guards against data leakage and sampling bias, shared data splits, checks for run-to-run variation and proper baselines.

Deep learning has become a standard tool in early drug discovery for two jobs: predicting how a small molecule sits in a protein's binding pocket, known as pose generation, and predicting how tightly it binds. Dozens of scoring functions now claim state-of-the-art results. In a Perspective in Nature Machine Intelligence, Viet-Khoa Tran-Nguyen and Pedro Ballester argue that those claims have become hard to compare, and set out guidelines for how such models should be evaluated.

Their list is short and practical. Training data, code and procedures should be disclosed so others can reproduce, reuse and scrutinise the work. Studies should guard against data leakage, where test molecules or proteins are too similar to training ones, against sampling bias and against flawed designs. Comparisons should use common data splits, check how much results vary from one training run to the next, and include proper baselines, so that a new method is measured against something simple as well as against the latest rival.

The paper builds on a body of work that has exposed the problem. Ballester's group has previously shown that scaffold splits, a common way of separating training and test molecules, overestimate virtual screening performance, and a 2026 benchmark called NextTopDocker, co-authored by both researchers, found limitations in current end-to-end machine-learning docking and strength in hybrid approaches that rescore classical results. Work on randomness in neural network comparisons, which the authors also cite, shows that a single run can flatter or bury a method.

For readers choosing a docking or affinity model, the guidelines double as a checklist for reading papers and model cards. A claim without shared splits, repeated runs and a simple baseline deserves less weight, however large the headline gain.

The limits are those of any Perspective. It proposes norms rather than presenting new results, and we could read only its abstract and reference list, not the full text, so we cannot report how it ranks specific tools. Guidelines also depend on enforcement: unless journals, reviewers and benchmark maintainers require these checks, the incentive to publish the most flattering number will remain.

Our take: Data leakage has inflated many headline results in this field, so a common checklist is overdue and useful to anyone choosing a docking or affinity model. Guidelines only help if journals and benchmark maintainers enforce them.

Source: Nature Machine Intelligence

More stories